Skip to main content

Table 3 Comparisons among different age groups in BPO with coexisting OAB (\( \overline{\mathrm{x}} \) ± s)

From: Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life

Age Group

50~years (n = 81)

60~years (n = 124)

70~years (n = 243)

80~year (n = 119)

90~years (n = 17)

Prostate volume (mL)

57.7 ± 24.1

56.9 ± 16.3

62.8 ± 26.5

69.6 ± 34.1

77.1 ± 20.4

P Value

 

0.214

0.235

0.358

0.347

Serum PSA (ng/mL)

3.2 ± 0.7

3.4 ± 0.6

3.7 ± 0.9

3.9 ± 1.2

4.2 ± 1.1

P Value

 

0.541

0.512

0.336

0.357

Testosterone (nmol/L)

17.2 ± 6.4

16.0 ± 5.7

12.7 ± 5.2

9.2 ± 3.9

7.1 ± 3.2

P Value

 

0.544

0.112

0.054

0.05

Qmax (mL/s)

11.5 ± 4.2

10.1 ± 3.4

10.1 ± 3.8

9.5 ± 4.1

8.8 ± 3.4

P Value

 

0.337

0.463

0.425

0.372

PVR (mL)

10.0 ± 4.2

12.6 ± 5.3

18.4 ± 6.7

26.8 ± 8.2

29.3 ± 8.8

P Value

 

0.130

0.688

0.393

0.246

BMI (kg/m2)

24.3 ± 3.6

25.2 ± 4.0

24.7 ± 4.2

23.9 ± 3.9

25.5 ± 2.3

P Value

 

0.051

0.221

0.768

0.095

IPSS

9.1 ± 3.3

14.3 ± 2.7

18.6 ± 3.9

24.7 ± 5.4

27.8 ± 6.6

P Value

 

0.031

0.028

0.000

0.001

QoL

4.2 ± 0.7

4.4 ± 0.7

4.7 ± 0.9

5.0 ± 1.2

5.4 ± 1.5

P Value

 

0.042

0.040

0.038

0.001

IIEF-5

10.5 ± 1.4

9.2 ± 0.9

7.7 ± 0.7

6.1 ± 0.8

5.6 ± 1.0

P Value

 

0.040

0.003

0.000

0.000

OABSS

7.2 ± 3.1

8.4 ± 3.6

9.1 ± 3.4

10.7 ± 4.0

11.6 ± 3.7

P Value

 

0.046

0.009

0.000

0.000

KHQ

23.4 ± 6.5

23.2 ± 7.3

28.6 ± 9.1

30.0 ± 9.5

28.7 ± 10.6

P Value

 

0.988

0.042

0.028

0.005

General health status

25.6 ± 8.9

25.3 ± 8.4

28.4 ± 9.7

28.6 ± 7.7

27.0 ± 10.6

P Value

 

0.596

0.048

0.000

0.000

Severity of urinary problems

29.4 ± 9.1

29.4 ± 10.2

29.5 ± 9.1

31.3 ± 9.7

26.5 ± 8.9

P Value

 

0.735

0.500

0.548

0.681

Role limitations

18.6 ± 8.8

18.3 ± 6.2

18.2 ± 5.9

19.8 ± 7.7

19.1 ± 7.5

P Value

 

0.996

0.451

0.007

0.633

Physical limitations

3.6 ± 2.0

3.2 ± 2.1

2.9 ± 1.5

3.2 ± 2.6

3.3 ± 1.8

P Value

 

0.793

0.659

0.594

0.771

Social limitations

16.9 ± 7.1

18.3 ± 7.9

19.7 ± 9.5

18.8 ± 9.1

18.9 ± 7.7

P Value

 

0.009

0.048

0.006

0.011

Personal relationships

2.2 ± 0.9

2.3 ± 0.9

2.2 ± 0.9

2.3 ± 1.0

2.2 ± 1.0

P Value

 

0.218

0.500

0.17

0.500

Emotions

8.3 ± 5.1

7.5 ± 3.7

6.9 ± 3.7

9.3 ± 5.3

7.0 ± 2.9

P Value

 

0.633

0.742

0.564

0.530

Sleep/Energy

29.8 ± 11.5

29.0 ± 9.3

37.5 ± 11.3

34.0 ± 9.8

33.5 ± 7.5

P Value

 

0.707

0.000

0.000

0.001

Coping urination problems

14.8 ± 4.8

15.5 ± 6.7

18.4 ± 8.0

15.9 ± 5.1

18.4 ± 6.1

P Value

 

0.467

0.001

0.058

0.000

  1. BPO Benign prostatic obstruction, OAB Overactive bladder syndrome, PSA Prostate-specific antigen, Qmax Maximum flow rate, PVR Postvoid residual urine volume, IPSS International prostate symptom score, QoL Quality of life, IIEF-5 International index of erectile function-5, OABSS Overactive bladder symptom score, KHQ King’s health questionnaire. P Value vs 50~ years